Inhibition of lincRNA-ROR also increases the sensitivity of BC cells to 5-Fluorouracil (5-FU) and paclitaxel by upregulating E-cadherin expression and downregulating Vimentin and N-cadherin expression. Here, CDH1 is linked to breast cancer.